Double-crane Pharmaceutical To Increase Production Capacity Of Plastic Bottles For Transfusion
This article was originally published in PharmAsia News
Executive Summary
Double-crane Pharmaceutical plans to invest over 90 million yuan to establish new lines to manufacture plastic bottles for medical transfusion. Parent Double-crane will loan 81.91 and 28.68 million yuan to its wholly-owned subsidiaries in Anhui and Wuhan, respectively. The Anhui base will set up two new and upgrade one transfusion plastic bottle line, while Wuhan will build one new line. When fully operational, the company's transfusion production lines will reach more than 40, with total manufacturing capacity of 1.3 billion bottles/packages. The production will shift toward more plastic packaging, which gives better profit margins. Double-crane Pharmaceutical aims to build up its transfusion business into the top local brand. (Click here for more - Chinese Language)